Stryker Corporation (SYK)
Market Cap | 124.41B |
Revenue (ttm) | 20.50B |
Net Income (ttm) | 3.17B |
Shares Out | 380.26M |
EPS (ttm) | 8.25 |
PE Ratio | 39.69 |
Forward PE | 27.33 |
Dividend | $3.20 (0.98%) |
Ex-Dividend Date | Mar 27, 2024 |
Volume | 229,563 |
Open | 330.38 |
Previous Close | 327.45 |
Day's Range | 326.75 - 330.39 |
52-Week Range | 249.98 - 361.41 |
Beta | 0.91 |
Analysts | Strong Buy |
Price Target | 338.80 (+3.69%) |
Earnings Date | Apr 30, 2024 |
About SYK
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The ... [Read more]
Financial Performance
In 2023, Stryker's revenue was $20.50 billion, an increase of 11.11% compared to the previous year's $18.45 billion. Earnings were $3.17 billion, an increase of 34.22%.
Financial StatementsAnalyst Forecast
According to 20 analysts, the average rating for SYK stock is "Strong Buy." The 12-month stock price forecast is $338.8, which is an increase of 3.69% from the latest price.
News
Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales
ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice ...
Stryker to announce financial results for its first quarter of fiscal year 2024
Portage, Michigan, April 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2024 on Tuesday, April 30, 2024. A press rele...
Stryker announces Annual Meeting of Shareholders
Portage, Michigan, March 26, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2024 Annual Meeting of Shareholders is scheduled as follows:
Stryker launches Gamma4 Hip Fracture Nailing System in Europe
AMSTERDAM--(BUSINESS WIRE)--Stryker's Gamma4 system is designed to treat hip and femur fractures and streamline procedural workflows for surgeons.
Stryker completes acquisition of SERF SAS
MAHWAH, N.J., USA, March 21, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a leading global medical technology company, announced today that it has completed the previously announced acquisition of SERF S...
First shoulder arthroplasty surgeries using Stryker's Blueprint® Mixed Reality Guidance System completed in Europe
AMSTERDAM--(BUSINESS WIRE)--The first shoulder arthroplasty surgeries using Stryker's Blueprint Mixed Reality Guidance System were successfully completed in Europe.
Stryker showcases commitment to innovation at AAOS 2024 Annual Meeting
MAHWAH, N.J. , Feb. 13, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technology, showcases its commitment to innovation and technological advancement in Joint Replacement with ...
Stryker declares a $0.80 per share quarterly dividend
Portage, Michigan, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable April 30, 2024 to shareholder...
Stryker to participate in Citi's 2024 Unplugged Medtech and Life Sciences Access Day
Portage, Michigan, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in Citi's 2024 Unplugged Medtech and Life Sciences Access Day on Thursday, February 29, 2024 at Citigroup Headq...
Medical-device makers' stocks jump as procedures keep going strong
Shares of Stryker Corp. SYK, +7.67%, Boston Scientific Corp. BSX, +3.50% and other medical-technology companies jumped Wednesday as sustained demand for medical procedures brightened investors' outloo...
Stryker CEO Kevin Lobo on M&A goals in 2024
Stryker CEO Kevin Lobo joins 'Money Movers' to discuss the company's quarterly earnings results, what offensive M&A could look like for Stryker, and what's driving the company's organic growth.
Stryker Expands Prophecy® Surgical Planning System to Include the New Footprint™, Offering Surgeons a Comprehensive View of the Foot and Ankle
PORTAGE, Mich.--(BUSINESS WIRE)--Stryker launched Prophecy Footprint, an expansion of the Prophecy Surgical Planning system, offering surgical planning across the entire foot.
Stryker forecasts strong 2024 as uptick in surgeries lift demand for devices
Stryker Corp forecast 2024 profit above Wall Street estimates on Tuesday, banking on a post-pandemic pick-up in volume for certain surgical procedures at hospitals to drive sales for its medical and s...
Final Trades: Abbvie, Stryker, Crown Castle, Marathon Petroleum
Jim Lebenthal, chief equity strategist at Cerity Partners, Jenny Harrington, Gilman Hill Asset Management CEO, Joe Terranova, senior managing director at Virtus Investment Partners, and Brenda Vingiel...
Health care stocks are back in favor and these 3 names could lead the rally, according to the charts
Here are three stocks in the health care sector that could provide further upside potential based on their improving technical characteristics.
First Shoulder Arthroplasty Surgeries Using Stryker's Blueprint® Mixed Reality Guidance System Completed at Mayo Clinic in Minnesota and at St. Joseph's Health Care London in Canada
KALAMAZOO, Mich.--(BUSINESS WIRE)--Stryker announced that the first shoulder arthroplasty surgeries using Blueprint® Mixed Reality Guidance have been successfully completed.
Stryker announces 2023 sales surpassed $20 billion
Portage, Michigan, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that it surpassed $20 billion in annual sales for the first time in its history during the month of December, 20...
Stryker to announce financial results for its fourth quarter and full year 2023
Portage, Michigan, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for fourth quarter and full year 2023 on Tuesday, January 30, 2024. A press rel...
Ozempic and other weight-loss drugs' popularity set these stocks up for big gains
Investors have such high hopes for popular weight-loss medications like Wegovy and Ozempic, the wonder drugs have sent shock waves through the stock market.
Stryker announces intent to acquire SERF SAS, enhancing its global joint replacement leadership
MAHWAH, N.J., USA , Dec. 18, 2023 /PRNewswire/ -- Stryker (NYSE: SYK), one of the world's leading medical technology companies, announced today that it has executed a binding offer to Menix to acquire...
Stryker announces Dr. Srikant Datar will retire from Board of Directors
Kalamazoo, Michigan, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that after 15 years of distinguished service, Dr. Srikant Datar has notified the Company that he will not stan...
Bulgarian parliament okays $1.5 billion purchase of Stryker fighting vehicles from US
The Bulgarian parliament on Thursday approved a $1.5 billion purchase of Stryker fighting vehicles from the United States to modernise the country's army and bring it in line with NATO standards, the ...
Stryker tightens profit forecast on steady demand for its medical devices
Stryker Corp on Thursday raised the lower end of its full-year profit forecast as the medtech company sees steady demand for its medical and surgical devices from a post-pandemic pick-up in volumes of...
Stryker reports third quarter 2023 operating results
Kalamazoo, Michigan, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2023: Third Quarter Results Reported net sales increased 9.6% to $4.9 bill...
Stryker to participate in the 6th Annual Evercore ISI HealthCONx Conference
Kalamazoo, Michigan, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 6th Annual Evercore ISI HealthCONx Conference on Wednesday, November 29, 2023 at the Kimpton EPIC Hote...